From an investors perspective, capital will remain interested, but it could be far more selective
Additionally, for those who are still actively losing weight or adjusting to their new body, it may not always be sensible to commit to permanent procedures too early in the journey
Balancing Benefits and Risks For most people with Type 2 diabetes or obesity, the benefits of GLP-1 agonists outweigh the rare eye-related risks
The improved regulation of glycemia by GLP-1RA, along with their ability to reduce lipid synthesis, enhanced beta oxidation of free fatty acids and autophagy of fat cells contributes to their lipid modulation properties (59)
But if that smaller volume is calorie-dense, the deficit you think you're in doesn't exist
The other is a tangible, engineered molecule with a specific, multi-faceted mechanism of action that is reshaping our understanding of metabolic control